Patents by Inventor Olivier Gevaert

Olivier Gevaert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250037788
    Abstract: Methods and systems for constructing gene modules with regulator genes and target genes are provided. A Gaussian mixed model can construct gene modules using RNA sequencing data. Sets of gene modules can be compared to identify shared or unique biological processes.
    Type: Application
    Filed: November 22, 2022
    Publication date: January 30, 2025
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Shaimaa Hesham Bakr, Olivier Gevaert
  • Publication number: 20240193729
    Abstract: Systems and methods for synthetic image generation include a method of generating synthetic histological slide images that includes translating each of several RNA-Seq records into a latent space, training a first diffusion model to produce a first synthetic histological slide image at a lower resolution using the translated RNA-Seq records and associated histological slides, training a second diffusion model to upscale lower resolution synthetic histological slide images produced by the first diffusion model to higher resolution synthetic histological slide images, obtaining a given RNA-Seq record, translating the given RNA-Seq record into the latent space, providing the latent representation of the given RNA-Seq record to the trained first diffusion model to generate a given lower resolution synthetic histological slide image, and providing the given lower resolution synthetic histological slide image to the trained second diffusion model to generate a given higher resolution synthetic histological slide im
    Type: Application
    Filed: December 13, 2023
    Publication date: June 13, 2024
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Francisco Carrillo-Perez, Marija Pizurica, Olivier Gevaert
  • Publication number: 20120053083
    Abstract: Present invention concerns a kit and an in vitro method, for evaluating a biological stage of an HCC tumour in an individual, based on a sample from the individual, comprising: deriving from the sample a profile data set, the profile data set on a the gene expression panel with the markers CCNG2, EGLN3, ERO1L, FGF21, MAT1A, RCL1 and WDR45L or a substantially similar marker, being a quantitative measure of the amount of a distinct RNA or protein constituent in the panel so that measurement of the constituents enables evaluation of the biological condition or the biological behaviour HCC tumours.
    Type: Application
    Filed: May 5, 2010
    Publication date: March 1, 2012
    Applicant: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Anneleen Daemen, Bart De Moor, Olivier Gevaert, Louis Libbrecht, Hannah Van Malenstein, Jos Van Pelt, Chris Verslype